ACHFF (Arch Biopartners) General and Admin. Expense: $1.19 Mil (TTM As of Mar. 2026)

What is Arch Biopartners General and Admin. Expense?

Arch Biopartners ACHFF +5.30% 26 General and Admin. Expense is $1.19 Mil as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Arch Biopartners's General and Admin. Expense for the three months ended in Mar. 2026 was $0.14 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1.19 Mil.

Arch Biopartners General and Admin. Expense Related Terms

Arch Biopartners General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners General and Admin. Expense Chart

Arch Biopartners Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

General and Admin. Expense

Get a 7-Day Free Trial

0.48

0.33

2.01

1.29

0.77

Arch Biopartners Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
General and Admin. Expense	Get a 7-Day Free Trial															0.20	0.17	0.22	0.67	0.14

26GF Score

Arch Biopartners Inc ACHFF

General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Arch Biopartners General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.19 Mil.

Frequently Asked Questions Learn more about General and Admin. Expense →

What does a General and Admin. Expense of $1.19 Mil mean?

Arch Biopartners (ACHFF) has a General and Admin. Expense of $1.19 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Arch Biopartners and its competitors.

Is Arch Biopartners' General and Admin. Expense too high?

Arch Biopartners' current General and Admin. Expense is $1.19 Mil. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.

How does Arch Biopartners' General and Admin. Expense compare to VRTX and REGN?

Arch Biopartners' General and Admin. Expense of $1.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good General and Admin. Expense for a Biotechnology company?

A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high General and Admin. Expense mean?

A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current General and Admin. Expense is $1.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Arch Biopartners stock overvalued right now?

Arch Biopartners (ACHFF) has a current General and Admin. Expense of $1.19 Mil. The current General and Admin. Expense is $1.19 Mil. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is General and Admin. Expense calculated?

General and Admin. Expense is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current General and Admin. Expense is $1.19 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Industry Healthcare Biotechnology

Comparable Companies TSX:RVX XCNQ:LOBE TSXV:GSD TSXV:TTI TSX:MDNA TSX:BCT TSX:MBX XCNQ:MDMA TSXV:MIR NEOE:BMND VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 8HA:Germany ARCH:Canada

Address 545 King Street West, Toronto, ON, CAN, M5V 1M1

Website https://www.archbiopartners.com

Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.

26GF Score

Get the complete analysis for ACHFF

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64

Price

View ACHFF Analysis

See General and Admin. Expense data for all stocks →